CA Patent

CA2621015C — New use for a composition comprising chloroprocaine hcl, a new composition comprising chloroprocaine hcl and a method for its manufacture

Assigned to Sintetica SA · Expires 2013-05-07 · 13y expired

What this patent protects

The present invention concerns a new use for a composition comprising chloroprocaine HCI, and in particular its use for the manufacture of a drug for intrathecal narcosis. The present invention also concerns a new composition comprising chloroprocaine HCI, being particularly suit…

USPTO Abstract

The present invention concerns a new use for a composition comprising chloroprocaine HCI, and in particular its use for the manufacture of a drug for intrathecal narcosis. The present invention also concerns a new composition comprising chloroprocaine HCI, being particularly suited to this new use, as well as a new method for manufacturing said composition.

Drugs covered by this patent

Patent Metadata

Patent number
CA2621015C
Jurisdiction
CA
Classification
Expires
2013-05-07
Drug substance claim
No
Drug product claim
No
Assignee
Sintetica SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.